Carlson R V, Bailey R R, Begg E J, Cowlishaw M G, Sharman J R
Clin Pharmacol Ther. 1986 Nov;40(5):561-6. doi: 10.1038/clpt.1986.224.
The antihypertensive efficacy and pharmacokinetics of a single 1 mg oral dose of doxazosin were investigated in five healthy male volunteers, six patients with renal failure not on hemodialysis, and four patients with end-stage renal failure studied between two hemodialyses. The dialyzability of doxazosin was studied in five patients. The maximum fall in blood pressure of both volunteers and patients occurred between 4 and 8 hours. In four of five volunteers the blood pressure had returned to baseline within 10 to 12 hours, whereas in the patients with renal failure it took as long as 72 hours. Maximum plasma concentrations were reached in 2.6 to 3.6 hours. The mean AUC did not differ significantly between the groups. The mean (SE) elimination t1/2 was 12.6 hours (3.3) in the volunteers and 13.3 hours (1.8) in the patients with renal insufficiency (not significant). Doxazosin was not appreciably dialyzable.
对5名健康男性志愿者、6名未进行血液透析的肾衰竭患者以及4名在两次血液透析之间接受研究的终末期肾衰竭患者,研究了单次口服1毫克多沙唑嗪的降压疗效和药代动力学。对5名患者研究了多沙唑嗪的透析性。志愿者和患者的血压最大降幅均出现在4至8小时之间。5名志愿者中有4名的血压在10至12小时内恢复至基线水平,而肾衰竭患者则长达72小时。在2.6至3.6小时达到最大血浆浓度。各组之间的平均曲线下面积无显著差异。志愿者的平均(标准误)消除半衰期为12.6小时(3.3),肾功能不全患者为13.3小时(1.8)(无显著差异)。多沙唑嗪不易被透析。